Evidence map›Paper›PMID 41728310›Full record

ArticlemedRxiv : the preprint server for health sciences2026

An Fc receptor and IgA functional signature identifies TB disease in children living with HIV.

Ye Jin Kang, Nannan Wang, Amyn Malik, Pei Lu, Irene Njuguna, Elizabeth Maleche-Obimbo, Sylvia M LaCourse, Jennifer Slyker, Dalton Wamalwa, Grace C John-Stewart and 3 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Ye Jin KangDivision of Pediatric Infectious Disease, Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX, USA.
Nannan WangDepartment of Immunology and Microbiology, University of Colorado Anshutz School of Medicine, Aurora, CO, USA.
Amyn MalikPeter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, TX, USA.
Pei LuDivision of Infectious Diseases and Geographic Medicine, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
Irene NjugunaMedical Research Department, Kenyatta National Hospital, Nairobi, Kenya.
Elizabeth Maleche-ObimboDepartment of Global Health, University of Washington, Seattle, WA, USA.
Sylvia M LaCourseDepartment of Global Health, University of Washington, Seattle, WA, USA.
Jennifer SlykerDepartment of Global Health, University of Washington, Seattle, WA, USA.
Dalton WamalwaDepartment of Pediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
Grace C John-StewartDepartment of Global Health, University of Washington, Seattle, WA, USA.
Chuangqi WangDepartment of Immunology and Microbiology, University of Colorado Anshutz School of Medicine, Aurora, CO, USA.
Lisa M CranmerDivision of Infectious Diseases, Department of Pediatrics, Emory University, Atlanta, GA, USA.
Lenette L LuDivision of Infectious Diseases and Geographic Medicine, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.

Funding

IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)75N93019C00071 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI FORTUNE, SARAH · 2019 to 2025
$57.3M
Pediatric Scientist Development Program (PSDP) [K12]K12HD000850 · NICHD · YALE UNIVERSITY · PI Sallie R. Permar · 1987 to 2026
$44.1M
Urgent Versus Post-Stabilization ART in HIV+ Children with Severe Co-infectionsR01HD023412 · NICHD · UNIVERSITY OF WASHINGTON · PI Grace C. John-Stewart, DALTON CHEKOKO WAMALWA · 1987 to 2026
$12.2M
Emory/Georgia TB Research Advancement Center (TRAC)P30AI168386 · NIAID · EMORY UNIVERSITY · PI Neel Rajnikant Gandhi, Jyothi Rengarajan · 2022 to 2026
$5.8M
Defining the antibody interface between Mycobacterium tuberculosis and host immunityR01AI158858 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI LU, LENETTE · 2021 to 2025
$2.1M
The role of antibodies in infant TB preventionK23AI143479 · NIAID · EMORY UNIVERSITY · PI CRANMER, LISA M · 2019 to 2023
$950k
Leveraging antibody-omics to prevent and detect TB in children affected by HIVR21AI192086 · NIAID · EMORY UNIVERSITY · PI Lisa M Cranmer, Aniruddh Sarkar · 2025 to 2026
$445k
NIAID NIH HHS K23 AI143479NIAID NIH HHS P30 AI168386NIAID NIH HHS R01 AI158858NIAID NIH HHS R21 AI192086NICHD NIH HHS K12 HD000850NICHD NIH HHS R01 HD023412NIH HHS 75N93019C00071Wellcome Trust
6 · The paper itself

Abstract

Background: Tuberculosis (TB) is a leading cause of morbidity and mortality among children living with HIV (CLHIV). Poor diagnostic performance is a significant contributor. Serological assays that determine levels of Methods: This study evaluated serum from a well-characterized cohort of Kenyan CLHIV via two orthogonal approaches: 1) longitudinally following over the course of TB treatment and 2) assessing a cross-section with and without clinical TB disease. For each individual sample, 13 antibody functional properties against 8 Findings: FcαR/CD89 immune complex formation with antibodies reactive to four Interpretation: An

Identifiers

PMID41728310
PMCPMC12919122

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.